Regulation of P-Glycoprotein in Renal Proximal Tubule Epithelial Cells by LPS and TNF-α by Heemskerk, Suzanne et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 525180, 10 pages
doi:10.1155/2010/525180
Research Article
Regulation of P-Glycoprotein in Renal Proximal Tubule Epithelial
Cellsby LPS andTNF-α
SuzanneHeemskerk,1,2 Janny G. P. Peters,1 JochemLouisse,1 SeilSagar,1 FransG.M.Russel,1
and Rosalinde Masereeuw1
1Department of Pharmacology and Toxicology, Nijmegen Medical Centre, Radboud University,
Nijmegen Centre for Molecular Life Sciences, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
2Department of Intensive Care Medicine, Nijmegen Medical Centre, Radboud University, 6500 HB Nijmegen, The Netherlands
Correspondence should be addressed to Rosalinde Masereeuw, r.masereeuw@pharmtox.umcn.nl
Received 2 July 2009; Revised 13 November 2009; Accepted 8 December 2009
Academic Editor: Xue-Ru Wu
Copyright © 2010 Suzanne Heemskerk et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
During endotoxemia, the ATP-dependent drug eﬄux pump P-glycoprotein (Abcb1/P-gp) is upregulated in kidney proximal tubule
epithelial cells. The signaling pathway through which lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α) regulates P-gp
expression and activity was investigated further in the present study. Exposure of rat kidney proximal tubule cells to TNF-α alone
or TNF-α and LPS increased P-gp gene and protein expression levels and eﬄux activity, suggesting de novo P-gp synthesis. Upon
exposuretoTNF-αincombinationwithLPS,P-gpactivityinrenalproximaltubulecellsisincreasedunderinﬂuenceofnitricoxide
(NO) produced by inducible NO synthase. Upon exposure to TNF-α alone, P-gp upregulation seems to involve TLR4 activation
and nuclear factor kappaB (NF-κB) translocation, a pathway that is likely independent of NO. These ﬁndings indicate that at least
two pathways regulate P-gp expression in the kidney during endotoxemia.
1.Introduction
P-glycoprotein (Abcb1/P-gp) is a member of the ATP binding
cassette (ABC) superfamily and is able to transport a broad
range of uncharged and cationic compounds. The apical
localization of P-gp in renal proximal tubule epithelial cells
is consistent with its importance in excretory transport into
urine [1]. In agreement with the detoxifying role of P-gp,
we recently found an upregulation of P-gp in rat kidney
during endotoxemia [2] and in mouse kidney after ischemia
reperfusion injury [3]. P-gp is likely to be regulated by
nitric oxide (NO) produced by renal inducible NO-synthase
(iNOS), because co-administration of an iNOS-inhibitor
attenuated the endotoxin-induced eﬀects on its expression in
rats [2]. An upregulation of important eﬄux pumps, like P-
gp, may diminish the accumulation of toxic compounds and
serves a protective function in acute kidney injury.
Using killiﬁsh renal proximal tubules, we found pre-
viously that NO has a regulatory role in the transport
activity of multidrug resistance protein 2 (Abcc2/Mrp2) via
an intracellular signaling pathway in response to the in vitro
action of several nephrotoxic chemicals [4]. This pathway
involved at least endothelin (ET) release, binding to the
basolateral ETB receptor, and activation of NOS, soluble
guanylyl cyclase (sGC) and protein kinase C (PKC) [5]. A
similar regulatory pathway was found for P-gp in rat brain
capillaries [6], where it was recently shown to be correlated
with an innate immune response [7, 8]. The inﬂammatory
mediator, tumor necrosis factor—alpha (TNF-α) signalled
through the TNF-receptor 1 (TNFR1) to increase P-gp
expression and transport activity by triggering the ET-NOS-
PKC pathway, ﬁnally activating the nuclear factor kappaB,
NF-κB[ 7].
As NF-κB was previously shown to be involved in P-gp
increase during renal toxicity [2, 3, 9], we hypothesized that
the same signaling pathway is responsible for the upregu-
lation of P-gp in the kidney during endotoxemia and that
NO is the central player in the ﬁeld. To test this hypothesis,
we used a spontaneously immortalized rat kidney proximal
tubular cell line and determined P-gp expression and activity2 Journal of Biomedicine and Biotechnology
after treating cells with endotoxin (lipopolysaccharide; LPS)
or the most important pro-inﬂammatory cytokine, TNF-
α. Our ﬁndings indicate that exposure to TNF-α in com-
bination with LPS increases P-gp activity in renal proximal
tubule cells under inﬂuence of NO produced by iNOS. Upon
exposuretoTNF-αalone,P-gpupregulationseemstoinvolve
TLR4 activation and NF-κB translocation, a pathway that
is likely independent of NO. These ﬁndings indicate that at
least two diﬀerent pathways regulate P-gp expression during
endotoxemia.
2.MaterialsandMethods
2.1. Chemicals. Dulbecco’s modiﬁed eagle’s medium
(DMEM), Hanks’ balanced salt solution (HBSS), insulin-
transferrin-selenium, and TRIzol reagent were from
Invitrogen Life Sciences (Breda, The Netherlands), fetal calf
serum from MP Biomedicals (Asse-Relegum, Belgium), 4-
(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (Hepes)
from Roche diagnostics (Almere, the Netherlands), calcein-
acetoxymethylester (calcein-AM) from Molecular Probes
(Eugene, OR), bisindolylmaleimide (BIM, Bruschwig
chemie, Amsterdam, the Netherlands), H398 from Alexis
(Lausen, Switzerland), antihuman Toll-like receptor (TLR)4
CD284/MD complex from Biolegend (San Diego, USA),
and 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ)
and SN50 from Calbiochem (Nottingham, U.K.). The
P-gp inhibitor, PSC-833, was a gift from Novartis Pharma
(Valspodar, Arnhem, The Netherlands). All other chemicals
were of analytical grade and purchased from Sigma-Aldrich
(Zwijndrecht, The Netherlands) or Merck (Darmstadt,
Germany).
2.2. Cell Culture and Analysis of P-gp Transport Activity. The
spontaneously immortalized epithelial cell line isolated from
rat kidney proximal tubule (GERP cells) was a kind gift of
the department of Veterinary Pharmacology, Pharmacy and
Toxicology of the University of Utrecht, The Netherlands.
These cells (passages 53201374) were cultured in collagen
coated culture ﬂasks in DMEM supplemented with 5%
fetal calf serum and 1% insulin-transferrin-selenium. We
previously demonstrated that P-gp activity in these cells was
highest just after reaching conﬂuency and decreased with
culturing time [10]. Cells were plated at a density of 40,000–
60,000cells/well for 3 days in a 24-well plate.
Culture medium was replaced for medium alone
(control group) or medium supplemented with the tested
compounds: lipopolysaccharide (10–100μg/mL LPS,
Escherichia coli 0127:B8), or TNF-α (1–100ng/mL), or the
NO-donor sodium nitroprusside (0.1–0.5mM SNP), or to
a combination of LPS and TNF-α, with the NO-scavenger
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide
(0.01–0.5mM PTIO). The concentration TNF-α relates to
plasma levels that can be reached in patients with septic
conditions [11]. Cells were also exposed to TNF-α in
combination with an inhibitor of sGC, ODQ, (0.01mM), an
inhibitor of PKC, BIM, (100nM), an inhibitor of TNFR1,
H398, (10μg/mL), the anti-human TLR4, CD284)/MD
complex, (5μg/mL), the selective I kappa B kinase (IKK)β
inhibitor, IMD-0354, (10–50μM), or the peptide inhibitor
for NF-κB nuclear translocation SN50 (1–1.8μM).
After treatment the transport activity of P-gp was
determined with the calcein accumulation assay [12], as
previously described [10]. The activity was determined by
calculating the ratio of cellular accumulation of ﬂuorescent
calceininthepresenceandabsenceoftheP-gpinhibitor,PSC
833, and control cells were set to 100%.
2.3. Determination of mRNA Expression. Cells were exposed
to medium (control), LPS, TNF-α or to a combination
of LPS and TNF-α for various time periods (2, 6, 24
hours) and were, subsequently, harvested for RNA iso-
lation (for 5 minutes at 1300g at room temperature).
Cell pellets were transferred in ice cold TRIzol reagent
(Invitrogen,Breda,theNetherlands)andRNAwasisolatedas
describedpreviously[13].QuantitativeRealTime-PCR(RQ-
PCR) on cDNA was performed according to the TaqMan
protocol in optical tubes using either the ABI PRISM
7700 single reporter Sequence Detection System (n =
6, Applied Biosystems, Zwijndrecht, The Netherlands) or
the ABI PRISM 7900HT Gene Expression Micro Fluidic
Card Sequence Detection System (3 pooled samples from 9
diﬀerent rats, Applied Biosystems) according to the manu-
facturer’s instructions. All experiments were performed in
triplicate. In rodents, two genes (Abcb1a and Abcb1b)e n c o d e
for P-gp, however, during endotoxemia only Abcb1b was
found to be diﬀerentially expressed [2]. Diﬀerent rat genes
(GAPDH: (Rn99999916 S1), Abcb1b: (Rn00561753 m1),
NOSII: (Rn00561646 m1), or Ednrb/endothelin receptor B:
Rn00569139 m1) were ampliﬁed with a pre-developed Gene
Expression Assay, provided by Applied Biosystems. The rela-
tive expression of genes in control cells were normalized for
the average cycle threshold (CT) value for the housekeeping
gene, GAPDH (CT = 15.9 ±1.0) and set to 1.
For the analysis of TNF-α receptor 1 (TNFR1), TNFR2,
and toll-like receptor-4 (TLR4) mRNA expression in GERP
cells exposed for 24 hours to TNF-α, PCR ampliﬁcation
was performed as previously described [14]. Gene-speciﬁc
primers were purchased from Biolegio (Nijmegen, The
Netherlands): rat TNFR1 (M63122; nt.983-1382), forward
primer: gggattcagctcctgtcaaa, reversed primer (atgaactc-
cttccagcgtgt; (M63122, nt.704-1902) forward primer: tcc-
cctgtaaggagaaacagaa, reversed primer: gctttttctccacaatcac-
ctc [15]. Rat TNFR2: (AF498039, nt. 579-1034), forward
primer: gttctctgacaccacatcatcc, reversed primer: gtcaatag-
gtgctgctgttcaa; (AF498039, nt.541-1242), forward primer:
aatggaaacgtgatatgcagtg, reversed primer: gctacagacgttcac-
gatgc [15]. Rat TLR4:( N M 019178, nt.2418-2546), for-
ward primer: gagccggaaagttattgtgg, reversed primer: agcaag-
gacttctccactttct [16]. Rat β-actin: forward primer: ctatgagct-
gctgacggtc, reversed primer: agtttcatggatgccacagg [14]. The
expected PCR products are: TNFR1-primer set 1: 400bp,
TNFR1-primer set 2: 1199bp, TNFR2-primer set 1: 456bp,
TNFR2-primer set 2: 702bp, TLR4: 129bp. MilliQ was used
as a negative control. The expression of the housekeeping
gene β-actin w a sm e a s u r e da sac o n t r o lf o rt h ep e r f o r m e d
PCR reaction.Journal of Biomedicine and Biotechnology 3
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Figure 1: P-gp activity and expression after exposure to TNF-α and/or LPS in GERP cells. (a)–(c) P-gp transport activity in GERP cells after
exposure to diﬀerent concentrations of TNF-α ((a) n = 4–6) or LPS ((b) n = 4) for 24 hours compared to control (cells exposed to culture
medium). ((c) n = 12) Optimal concentrations of both sepsis mediators were used for exposure to GERP cells for 24 hours. P-gp activity
was determined using the calcein accumulation assay. ((d) n = 4) Abcb1b expression in GERP cells (control; open bars) after exposure to
either 10μg/mL LPS (closed bars), 10ng/mL TNF-α ( s t r i p e db a r s )o rb o t h1 0μg/mL LPS and 10ng/mL TNF-α (chequered bars) for 2, 6 or
24 hours. mRNA levels were determined with RQ-PCR and expression was normalized for the GAPDH CT value (15.9 ± 1.0). ((e) n = 4)
P-gp protein expression in GERP cells (control; lanes 1, 2, 7 and 8) after exposure to either 10μg/mL LPS (lanes 3 and 4), 10ng/mL TNF-α
(lanes 5 and 6) or to both 10μg/mL LPS and 10ng/mL TNF-α (lanes 9 and 10) for 24 hours. Total cell lysate fractions of GERP cells were
used and expression of P-gp was determined by Western blotting. Relative pixel intensities (ratio P-gp/β-actin) were determined through
image analysis. Data are expressed as mean ± SEM. Signiﬁcantly diﬀerent compared to control cells (∗: P<. 05, ∗∗∗: P<. 001).4 Journal of Biomedicine and Biotechnology
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Figure 2: Expression of iNOS and eﬀe c to fN Oo nA b c b 1 / P - g pa c t i v i t yi nG E R Pc e l l s .( ( a )n = 4) NOSII expression in GERP cells after
exposure to either 10μg/mL LPS (closed bars), 10ng/mL TNF-α (striped bars) or both 10μg/mL LPS and 10ng/mL TNF-α (chequered bars)
for 2, 6 or 24 hours (n = 4). mRNA levels were determined with RQ-PCR and expression was normalized for the GAPDH CT value. ((b)
n = 4) iNOS protein expression in GERP cells (control; lanes 1 and 2) after exposure to either 10μg/mL LPS (lanes 3 and 4), 10ng/mL
TNF-α (lanes 5 and 6) or both 10μg/mL LPS and 10ng/mL TNF-α (lanes 7 and 8) for 6 hours. ((c) n = 3–5) P-gp transport activity in GERP
cells after exposure to 10ng/mL TNF-α or both 10μg/mL LPS and 10ng/mL TNF-α in combination with 50 or 10μM of the NO-scavenger
PTIO, respectively, for 24 hours compared to control (cells exposed to culture medium). ((d) n = 4) P-gp protein expression in GERP cells
(control; lanes 1 and 2) after exposure to 100μM SNP (lanes 3 and 4) for 1 hour with 5 hours recovery. ((e) n = 4) P-gp transport activity
in GERP cells, compared control, after exposure to 100 or 500μM SNP for 6 hours or for 1 hour with a subsequent recovery period of 5
hours. Total cell fractions of GERP cells were used and expression of iNOS (b) or P-gp (d) was determined by Western blotting. Relative pixel
intensities (ratio iNOS/β-actin (b) and ratio P-gp/β-actin (d)) were determined through image analysis. Data are expressed as mean ± SEM.
Signiﬁcantly diﬀerent compared to control (∗: P<. 05, ∗∗; P<. 01, ∗∗∗: P<. 001).
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Figure 3: Lack of involvement of cGMP and PKC in P-gp regulation. ((a) n = 3–6) P-gp transport activity in GERP cells after exposure to
10ng/mLTNF-αincombinationwith10μMofthesGCinhibitorODQfor24hourscomparedtocontrol(cellsexposedtoculturemedium).
((b) n = 3 )P - g pt r a n s p o r ta c t i v i t yi nG E R Pc e l l sa f t e re x p o s u r et o1 0n g / m LT N F - α in combination with 100nM of the PKC inhibitor BIM
for 24 hours compared to control. Data are expressed as mean ± SEM. Signiﬁcantly diﬀerent compared to control (∗: P<. 05; ∗∗∗: P<. 001).
Treatment with ODQ or BIM alone showed no signiﬁcant diﬀerence compared to control.6 Journal of Biomedicine and Biotechnology
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Figure 4: Role of TNF receptors and toll-like receptor 4 in modulation of P-gp activity in GERP cells. (a) TNFR1, TNFR2 and TLR4 mRNA
expression was analyzed in GERP cells (control; lane 1 and 2) exposed for 24 hours to TNF-α (lanes 3 and 4) using PCR. For TNFR1 and
TNFR2 two diﬀerent primer sets were used, for TLR4 only one primer set was used. MilliQ (MQ) was used as a negative control. For both
experiments the expression of the housekeeping gene β-actin was performed as a control for the performed PCR reaction. ((b) n = 3) P-gp
transport activity in GERP cells after exposure to 10ng/mL TNF-α in combination with 10mg/mL of the TNFR1 inhibitor H398 for 24
hours compared to control (cells exposed to culture medium). ((c) n = 7) P-gp transport activity in GERP cells after exposure to 10ng/mL
TNF-α in combination with 5ng/mL of the antibody against human TLR4 for 24 hours compared to control. Data are expressed as mean ±
SEM. Signiﬁcantly diﬀerent compared to control (∗∗∗: P<. 001) or to TNF-α (##; P<. 01). Treatment with H398 or anti-TLR4 alone showed
no signiﬁcant diﬀerence compared to control.
2.4. Western Blotting. Cells were harvested after exposure
to diﬀerent inﬂammatory mediators and lysed with 0.1%
Triton X-100 supplemented with protease inhibitors (1mM
PMSF, 10μM E64, 1μg/mL pepstatin, 5μg/mL leupeptin
and 1μg/mL aprotinin) during 30 minutes on ice. The
amount of protein in cell lysates was determined with
the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules,
CA) using bovine serum albumin as standard and samples
were subjected to Western blotting as described previously
[17].
Samples were separated on a 6% sodium dodecylsulfate
polyacrylamide gel and transferred to Hybond-C pure nitro-
cellulose membrane (Amersham, Buckinghamshire, UK).
The membrane was incubated overnight at 4◦C with the
primary antibodies against iNOS (1 : 1000, according
to [18]), ABCB1/P-gp (1 : 200, C219, DakoCytomation,
Denmark), or β-actin (1 : 10000, Sigma-Aldrich) in Tris-
buﬀered saline supplemented with 0.1% Tween-20 (TBS-T)
and 1% non-fat dried milk.
Subsequently, the membranes were washed three times
in TBS-T, blocked in TBS-T containing 5% non-fat dried
milk, washed three times in TBS-T again, and incubated
with aﬃnity-puriﬁed horseradish peroxidase-conjugated
goat antirabbit IgG (Sigma-Aldrich) for iNOS or goat
antimouse IgG (Sigma-Aldrich) for P-gp and β-actin diluted
1 : 5000 in TBS-T for 1 hour at room temperature. The
washing steps were repeated, after which the membranes
were visualized with enhanced chemiluminescence (Pierce
Chemical, Rockford, IL). For semiquantiﬁcation, the pixel
intensity of the bands was measured using Scion Image ver-
sion beta 4.02 for Windows (Scion Corporation, Frederick,
MD).Journal of Biomedicine and Biotechnology 7
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Figure 5: Role of NF-κB in modulation of P-gp activity in GERP cells. ((a) n = 4) P-gp transport activity in GERP cells after exposure
to 10ng/mL TNF-α in combination with 5μMo ft h es e l e c t i v eI K K β inhibitor IMD-0354 compared to control (cells exposed to culture
medium). ((b) n = 7 )P - g pt r a n s p o r ta c t i v i t yi nG E R Pc e l l sa f t e re x p o s u r et o1 0n g / m LT N F - α in combination with 1.8μMo fac e l l -
permeable inhibitor peptide that interferes with NF-κB nuclear translocation, SN50, for 24 hours compared to control. Data are expressed
as mean ± SEM. Signiﬁcantly diﬀerent compared to control cells (∗∗; P<. 01, ∗∗∗: P<. 001) or to TNF-α (##:P<. 001). Treatment with
SN50 alone showed no, but with IMD-0354 alone did show signiﬁcant diﬀerence compared to control.
2.5.DataAnalysis. Valuesaregivenasmean ±SEM.Analysis
was performed using GraphPad Prism 4.03 for Windows
(Graphpad Software Inc., San Diego, CA, USA) and SPSS
(version 12.0.1 for Windows, Chicago, IL). Diﬀerences
between the experimental groups were tested using one-way
ANOVA with Bonferroni’s correction or two-way repeated
measurements ANOVA. A two-sided P value <. 05 was
considered signiﬁcantly diﬀerent.
3. Results andDiscussion
3.1. Eﬀect of Inﬂammatory Mediators on P-gp Expression and
Activity. Treatment of GERP cells with 10μg/mL LPS and/or
10–100ng/mL TNF-α for 24 hours resulted in an increase in
P-gp activity (Figures 1(a)–1(c), P<. 05). As 10ng/mL is a
clinically relevant concentration [11] and a 10-fold higher
TNF-α concentration or combination of TNF-α and LPS did
not further increase P-gp activity, we used a concentration of
10ng/mL TNF-α for additional experiments. In accordance,
we also observed an upregulation in Abcb1b expression after
exposuretoTNF-α,LPS,oracombinationofTNF-αandLPS
(Figure 1(d)), which was accompanied by an increase in P-
gp protein expression (Figure 1(e)), suggesting de novo P-gp
synthesis. This ﬁnding is in agreement with previous studies
in mice and rats in which the upregulation of renal P-gp was
demonstrated after in vivo LPS exposure [2, 19, 20].
3.2. P-gp Expression and Activity Also Independent of NO. We
previously suggested that P-gp is likely to be regulated by NO
produced by iNOS, as coadministration of aminoguanidine
reversed the induction in iNOS, reduced renal damage and
attenuated the endotoxin-induced eﬀects on its expression
in rats [2]. In agreement, we show here that both iNOS
mRNA (Figure 2(a), P<. 001) and protein (Figure 2(b))a r e
upregulated when cells are exposed to LPS, either alone or
in combination with TNF-α.T r e a t m e n tw i t hT N F - α alone,
however, only marginally induced NOSII mRNA, but had no
eﬀect on iNOS protein (Figures 2(a),a n d2(b)).
To determine the NO-dependency of the upregulation
of P-gp, GERP cells were co-treated with the NO-scavenger
PTIO or exposed to the NO donor SNP. Indeed, the
P-gp eﬄux activity was not signiﬁcantly diﬀerent from
controlanymoreafterco-treatmentwithPTIO(Figure 2(c)).
Remarkably, SNP, did not aﬀect Abcb1b (data not shown)
and P-gp protein expression (Figure 2(d)) and its activity
was slightly, though not signiﬁcantly, upregulated after 1
hourexposureand5hoursrecovery(Figure 2(e)).Prolonged
exposure times to SNP resulted in cytotoxicity (data not
shown). This is in contrast with previous ﬁndings demon-
strating that NO, released by the NO donor S-nitroso-N-
acetylpenicillamine, was able to upregulate P-gp expression
in the human CaCo2 cell line [21]. However, SNP produces
besides NO also iron and cyanide [22], so it is not clear
whether only eﬀects of NO on P-gp expression and activity
were measured. In contrast to LPS, our ﬁndings indicate
that P-gp signaling seems largely NO-independent after
exposure to TNF-α. In addition, this signaling pathway may
be dependent on the type of cytokine as NO mediated
increased P-gp activity after stimulation with interferon-
γ [21]. Furthermore, it was recently demonstrated that in
vivo inhibition of NOS and subsequent NO production
with L-NAME did not aﬀect blood-brain barrier P-gp
function during endotoxemia [23], which contradicts with8 Journal of Biomedicine and Biotechnology
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Figure 6: Scheme illustrating the proposed sequence of events by which inﬂammatory mediators increase P-gp-mediated transport in GERP cells.
(a) NO-dependent pathway after exposure to LPS directly or indirectly via TLR4. (b) NO-independent pathway after exposure to TNF-α.
This pathway involves the activation of NF-κB inducing kinase (NIK) by TNF receptor associated factor family (TRAF) 2 and, consequently,
the activation of NF-κB or the activation of TLR4 leading to the activation of IKKβ by TRAF2 and consequently the activation of NF-κB.
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previous in vitro ﬁndings in isolated rat brain capillaries
[7, 8].
3.3. Regulation of P-gp Activity by TNF-α. To dissect the sig-
naling pathway through which exposure to TNF-α increased
P-gp expression and activity we used various pharmaco-
logical agents. Since NO is a well-known activator of sGC,
which is in turn involved in the PKC signalling pathway
[5], the eﬀects of the sGC inhibitor ODQ (Figure 3(a))
and the PKC inhibitor BIM (Figure 3(b)) on P-gp activity
were examined. Importantly, none of the two substances
could prevent the upregulation of P-gp caused by TNF-α,
suggesting that a novel pathway mediates P-gp activity in
GERP cells and/or that the NO-sGC-PKC pathway is not
activated in our cell line. This ﬁnding is in contrast with
previous studies using killiﬁsh renal proximal tubules and
brain capillary membranes [4–7].
LPS signals through toll-like receptor-4 (TLR-4) and
TNF-α mediates their eﬀect by binding to TNFR1 (p55)
and TNFR2 (p75), which are known to be expressed in
the kidney and their expression patterns are modulated
duringimmune-mediatedandischemicrenalinjury[24,25].
Figure 4(a) shows that TNFR1 and TLR4 are expressed in
the GERP cell line, whereas TNFR2 expression could not
be detected. To conﬁrm the results of the PCR analysis,
we used inhibitors of and/or antibodies against TNFR1
(H398, Figure 4(b)) and TLR4 (anti-TLR4, Figure 4(c))a n d
determined P-gp activity. Exposure to H398 could not
prevent the upregulation of P-gp by TNF-α, suggesting
that although TNFR1 is expressed in GERP cells it may
not be involved in P-gp regulation (Figure 4(b)). Many cell
types require cooperation between TNFR1 and TNFR2 to
generate TNF responses [26], and the absence of TNFR2
in our cells could explain why TNFR1 did not aﬀect the
regulation of P-gp activity by TNF-α. On the other hand,Journal of Biomedicine and Biotechnology 9
inhibition of TLR4 resulted in an attenuation in P-gp activity
(Figure 4(c)), and an involvement of this toll-like receptor
is in agreement with previous ﬁndings in brain capillaries
[8].
Since the transcription factor NF-κB is the downstream
eﬀector of TNF-α signalling in brain capillaries [7], we
wondered whether the same holds true for the regulation
of P-gp activity by TNF-α in this proximal tubular cell line.
GERP cells were exposed for 24 hours to the selective I
kappa B kinase (IKK)β inhibitor, IMD-0354 (Figure 5(a)),
or SN50 (Figure 5(b)). Remarkably, IMD-0354 alone gave
a signiﬁcant upregulation of P-gp activity compared to
control cells (Figure 5(a), P<. 01), indicating that the
compound itself has an eﬀect on P-gp. An alternative
explanation would be that IMD-0354 may have potentiated
the responses to TNF-α and, therefore, NF-κB inhibits
P-gp activity and blockade of nuclear translocation of
this transcription factor leads to enhancement of TNF-α
induction. Exposing the cells to the combination of SN50,
a cell-permeable inhibitor peptide that interferes with NF-
κB nuclear translocation, and TNF-α slightly reversed the
increase in P-gp activity upon TNF-α treatment (Figure 5(b)
NS), suggesting a role for the transcription factor. Although
higher SN50 concentrations have been used before [7] this
was not feasible in our cell system due to solubility problems.
H e n c e ,ar o l ef o rN F - κB was demonstrated previously
after detrimental stimuli. Thevenod et al. showed that an
upregulation of P-gp by NF-κB is potentially important
for protecting renal proximal tubule cells from apoptosis
induced by cadmium- and reactive oxygen species (ROS)
[9]. In addition, an increase in P-gp expression and/or
activity by TNF-α was reported for primary rat hepatocytes
[27], a rat hepatoma cell line [28]a n dm o u s el i v e r[ 29],
which are also NF-κBd e p e n d e n t[ 28]. Furthermore, an NF-
κB binding site was found in the promoter region of the
Abcb1 gene [30]. Therefore, we suggest that NF-κBm i g h t
have a central role in the signal transduction mechanism
and could be involved in two distinct signalling pathways
of P-gp. This nuclear factor is probably activated directly
by proinﬂammatory cytokines and NO, and indirectly via
TLR4. However, more research is needed to further unravel
the regulation mechanism of P-gp in the GERP cell line
and the inﬂammatory response on the activity of the eﬄux
pump.
4. Conclusions
In accordance with previous rat endotoxemia studies, the
upregulation of P-gp expression and activity after exposure
to LPS in combination with TNF-α in the cultured renal
proximal tubule cells are under inﬂuence of NO produced
by iNOS. On the other hand, the signaling pathway of
TNF-α alone leading to P-gp upregulation seems to involve
TLR4 activation and NF-κB translocation, which results in
de novo synthesis of P-gp. Figure 6 summarizes the sequence
of events. Our ﬁndings indicate that at least two diﬀerent
pathways regulate P-gp in renal proximal tubule cells during
endotoxemia.
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